PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES IN CHEMOTHERAPY
PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES IN CHEMOTHERAPY
批准号:
3178387
负责人:
SHIH HSI CHU
金额:
$14.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-09-01 至 1993-11-30
关键词:
antimetabolites drug design /synthesis /production drug metabolism drug screening /evaluation enzyme inhibitors floxuridine neoplasm /cancer chemotherapy neoplasm /cancer pharmacology nucleic acid metabolism pentosyltransferase pyrimidine nucleosides thymidylate synthase uracil uridine phosphorylase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The objectives of this grant proposal are:
1. Chemical synthesis of analogs and derivatives of BAU
(5-benzylacyclouridine) and BBAU (5-benzyloxybenzylacyclouridine), potent
inhibitors of uridine phosphorylase and potentiators of the anti-tumor
action of FUdR, designed to improve facility of clinical use, to produce
new anti-tumor drugs and pro-drugs, and to explore further their biological
properties.
2. Biological testing of these new agents as inhibitors of uridine
phosphorylase and, where indicated, thymidine phosphorylase, as transport
inhibitors, anti-tumor agents and potentiators both in vitro and in vivo,
and as tools for obtaining new biochemical knowledge related to nucleic
acid metabolism.
These studies will be performed in collaboration with colleagues in the
Roger Williams Cancer Center.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
New analogues of benzylacyclouridines, specific and potent inhibitors of uridine phosphorylase from human and mouse livers.
苄基环尿苷的新类似物,来自人和小鼠肝脏的尿苷磷酸化酶的特异性和有效抑制剂。
DOI:
10.1016/0006-2952(87)90150-x
发表时间:
1987
期刊:
Biochemical pharmacology
影响因子:
5.8
作者:
[Naguib,FN, elKouni,MH, Chu,SH, Cha,S]
通讯作者:
Cha,S
Effect of the N-glycosidic bond conformation and modifications in the pentose moiety on the binding of nucleoside ligands to uridine phosphorylase.
N-糖苷键构象和戊糖部分的修饰对核苷配体与尿苷磷酸化酶结合的影响。
DOI:
--
发表时间:
1988
期刊:
Molecular pharmacology
影响因子:
3.6
作者:
[elKouni,MH, Naguib,FN, Chu,SH, Cha,SM, Ueda,T, Gosselin,G, Imbach,JL, Shealy,YF, Otter,BA]
通讯作者:
Otter,BA
Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line.
5-benzyloxybenzyloxybenzylcyclouridine 在人结肠癌细胞系中增强 5-氟-2-脱氧尿苷抗肿瘤活性。
DOI:
--
发表时间:
1992
期刊:
Cancer research
影响因子:
11.2
作者:
[Chu,E, Chu,MY, Darnowski,JW, Chen,ZH, Pan,BC, Chu,SH]
通讯作者:
Chu,SH
Inhibition of uridine phosphorylase from Escherichia coli by benzylacyclouridines.
苄基环尿苷对大肠杆菌尿苷磷酸化酶的抑制。
DOI:
10.1016/0006-2952(86)90675-1
发表时间:
1986
期刊:
Biochemical pharmacology
影响因子:
5.8
作者:
[Park,KS, elKouni,MH, Krenitsky,TA, Chu,SH, Cha,S]
通讯作者:
Cha,S
PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES IN CHEMOTHERAPY
-
批准号:3178386
-
项目类别:
-
资助金额:$14.23万
-
财政年份:1985
-
负责人:SHIH HSI CHU
-
依托单位:
PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES/CANCER CHEMOTHERAPY
-
批准号:3178378
-
项目类别:
-
资助金额:$9.5万
-
财政年份:1985
-
负责人:SHIH HSI CHU
-
依托单位:
PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES/CANCER CHEMOTHERAPY
-
批准号:3178385
-
项目类别:
-
资助金额:$10.12万
-
财政年份:1985
-
负责人:SHIH HSI CHU
-
依托单位:
PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES/CANCER CHEMOTHERAPY
-
批准号:3178384
-
项目类别:
-
资助金额:$9.51万
-
财政年份:1985
-
负责人:SHIH HSI CHU
-
依托单位:
MEDICINAL CHEMISTRY FACILITY
-
批准号:4690432
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:SHIH HSI CHU
-
依托单位: